These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17983803

  • 1. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M, Bergmann G, Krebs I, End C, Lyer S, Hilberg F, Helmke B, Gassler N, Autschbach F, Bikker F, Strobel-Freidekind O, Gronert-Sum S, Benner A, Blaich S, Wittig R, Hudler M, Ligtenberg AJ, Madsen J, Holmskov U, Annese V, Latiano A, Schirmacher P, Amerongen AV, D'Amato M, Kioschis P, Hafner M, Poustka A, Mollenhauer J.
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [Abstract] [Full Text] [Related]

  • 2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [Abstract] [Full Text] [Related]

  • 3. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, Pfennig S, Haller D, Griga T, Klein W, Epplen JT, Folwaczny C, Lohse P, Göke B, Ochsenkühn T, Mussack T, Folwaczny M, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [Abstract] [Full Text] [Related]

  • 4. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, Radford-Smith GL.
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [Abstract] [Full Text] [Related]

  • 5. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B, Autschbach F, Kim S, Lasitschka F, Strauch U, Rogler G, Gdynia G, Li L, Gretz N, Macher-Goeppinger S, Sido B, Schirmacher P, Meuer SC, Roth W.
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [Abstract] [Full Text] [Related]

  • 6. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A, Palmieri O, Valvano MR, D'Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):241-8. PubMed ID: 17944996
    [Abstract] [Full Text] [Related]

  • 7. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A, Sakaida I, Higaki S, Kubo Y, Uchida K, Okita K.
    J Gastroenterol; 2002 Feb 01; 37(5):345-53. PubMed ID: 12051533
    [Abstract] [Full Text] [Related]

  • 8. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease.
    Autschbach F, Giese T, Gassler N, Sido B, Heuschen G, Heuschen U, Zuna I, Schulz P, Weckauf H, Berger I, Otto HF, Meuer SC.
    Virchows Arch; 2002 Nov 01; 441(5):500-13. PubMed ID: 12447682
    [Abstract] [Full Text] [Related]

  • 9. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
    Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A.
    Am J Gastroenterol; 2005 Apr 01; 100(4):886-95. PubMed ID: 15784037
    [Abstract] [Full Text] [Related]

  • 10. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH, Olsen JE, Jain S, Doe WF.
    J Pathol; 2001 Dec 01; 195(5):609-15. PubMed ID: 11745698
    [Abstract] [Full Text] [Related]

  • 11. Role of alkaline phosphatase in colitis in man and rats.
    Tuin A, Poelstra K, de Jager-Krikken A, Bok L, Raaben W, Velders MP, Dijkstra G.
    Gut; 2009 Mar 01; 58(3):379-87. PubMed ID: 18852260
    [Abstract] [Full Text] [Related]

  • 12. Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease.
    Nishiwaki T, Ina K, Goto H, Watanabe O, Tsuzuki T, Furuta R, Ando T, Hibi K, Kusugami K.
    J Gastroenterol; 2005 Feb 01; 40(2):128-36. PubMed ID: 15770395
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C, Yu T, Shi Y, Ma C, Yang W, Fang L, Sun M, Wu W, Xiao F, Guo F, Chen M, Yang H, Qian J, Cong Y, Liu Z.
    Gastroenterology; 2017 May 01; 152(6):1434-1448.e15. PubMed ID: 28193514
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S, Hofbauer K, Dambacher J, Schnitzler F, Staudinger T, Pfennig S, Seiderer J, Tillack C, Konrad A, Göke B, Ochsenkühn T, Lohse P.
    Am J Gastroenterol; 2006 Jan 01; 101(1):99-106. PubMed ID: 16405540
    [Abstract] [Full Text] [Related]

  • 15. Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion.
    Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, Hellmig S, Nikolaus S, Fölsch UR, Helmke B, Autschbach F, Schirmacher P, Kioschis P, Hafner M, Poustka A, Mollenhauer J, Schreiber S.
    J Immunol; 2007 Jun 15; 178(12):8203-11. PubMed ID: 17548659
    [Abstract] [Full Text] [Related]

  • 16. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L, Kuiper I, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep 15; 201(1):28-36. PubMed ID: 12950014
    [Abstract] [Full Text] [Related]

  • 17. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P, Lofberg R, Kuznetsov NV, Gielen AW, Persson JO, Sundberg R, Hellstrom K, Eriksson A, Befrits R, Ost A, von Stein OD.
    Gastroenterology; 2008 Jun 15; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [Abstract] [Full Text] [Related]

  • 18. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
    Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, Doni A, Fantini M, Sturm A, Borroni E, Repici A, Locati M, Malesci A, Dejana E, Danese S.
    Gastroenterology; 2008 Jul 15; 135(1):173-84. PubMed ID: 18514073
    [Abstract] [Full Text] [Related]

  • 19. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T, Yamaguchi K, Scherl E, Du B, Tai HH, Greifer M, Petrovic L, Daikoku T, Dey SK, Subbaramaiah K, Dannenberg AJ.
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb 15; 290(2):G361-8. PubMed ID: 16195422
    [Abstract] [Full Text] [Related]

  • 20. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer.
    Mollenhauer J, Herbertz S, Holmskov U, Tolnay M, Krebs I, Merlo A, Schrøder HD, Maier D, Breitling F, Wiemann S, Gröne HJ, Poustka A.
    Cancer Res; 2000 Mar 15; 60(6):1704-10. PubMed ID: 10749143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.